Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Bookman

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
The Journal of Experimental Medicine|February 1, 1987
Generation of diversity in T cell receptor repertoire specific for pigeon cytochrome cS B Sorger, S M Hedrick, P J Fink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxelM A Bookman, H Malmström, G Bolis, et al.
Annals of Internal Medicine|February 1, 1985
Salmonella typhimurium enteritis and bacteremia in the acquired immunodeficiency syndromeP D Smith, A M Macher, M A Bookman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
High-dose carboplatin and recombinant granulocyte-macrophage colony-stimulating factor in advanced-stage recurrent ovarian cancerE Reed, J Janik, M A Bookman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cellsR J Schilder, S Johnson, J Gallo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology GroupM A Bookman, W P McGuire, D Kilpatrick, et al.
Immunotechnology : an International Journal of Immunological Engineering|May 1, 1995
In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody libraryR Schier, J D Marks, E J Wolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancerL H Pai, M A Bookman, R F Ozols, et al.
Cancer Research|December 1, 1995
Targeting c-erbB-2 expressing tumors using single-chain Fv monomers and dimersM S Tai, J E McCartney, G P Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinomaR G Steis, J A Carrasquillo, R McCabe, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Experimental Medicine|February 1, 1987
Generation of diversity in T cell receptor repertoire specific for pigeon cytochrome cS B Sorger, S M Hedrick, P J Fink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxelM A Bookman, H Malmström, G Bolis, et al.
Annals of Internal Medicine|February 1, 1985
Salmonella typhimurium enteritis and bacteremia in the acquired immunodeficiency syndromeP D Smith, A M Macher, M A Bookman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
High-dose carboplatin and recombinant granulocyte-macrophage colony-stimulating factor in advanced-stage recurrent ovarian cancerE Reed, J Janik, M A Bookman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cellsR J Schilder, S Johnson, J Gallo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology GroupM A Bookman, W P McGuire, D Kilpatrick, et al.
Immunotechnology : an International Journal of Immunological Engineering|May 1, 1995
In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody libraryR Schier, J D Marks, E J Wolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancerL H Pai, M A Bookman, R F Ozols, et al.
Cancer Research|December 1, 1995
Targeting c-erbB-2 expressing tumors using single-chain Fv monomers and dimersM S Tai, J E McCartney, G P Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinomaR G Steis, J A Carrasquillo, R McCabe, et al.
Pageof 8